<div class="container">

<table style="width: 100%;"><tr>
<td>alog_pcfb</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Studies of alogliptin for lowering blood glucose concentration in patients with type II diabetes</h2>

<h3>Description</h3>

<p>A dataset from a systematic review of Randomised-Controlled Trials (RCTs) comparing different doses of
alogliptin with placebo (Langford et al. 2016). The systematic review was simply performed and was intended to
provide data to illustrate a statistical methodology rather than for clinical inference. Alogliptin is
a treatment aimed at reducing blood glucose concentration in type II diabetes. The outcome is continuous,
and aggregate data responses correspond to the mean change in HbA1c from baseline to follow-up.
The dataset includes 14 Randomised-Controlled Trials (RCTs), comparing 5
different doses of alogliptin with placebo, leading to 6 different treatments (combination of dose and agent)
within the network.
</p>


<h3>Usage</h3>

<pre><code class="language-R">alog_pcfb
</code></pre>


<h3>Format</h3>

<p>A data frame in long format (one row per arm and study), with 46 rows and 9 variables:
</p>

<ul>
<li> <p><code>studyID</code> Study identifiers
</p>
</li>
<li> <p><code>clinicaltrialGov_ID</code> The clinicaltrial.gov ID code
</p>
</li>
<li> <p><code>agent</code> Character data indicating the agent to which participants were randomised
</p>
</li>
<li> <p><code>dose</code> Numeric data indicating the standardised dose received
</p>
</li>
<li> <p><code>treatment</code> Character data indicating the treatment (combination of agent and dose) to which participants were randomised
</p>
</li>
<li> <p><code>time</code> Numeric data indicating the time at which the observation was measured (given in weeks)
</p>
</li>
<li> <p><code>y</code> Numeric data indicating the mean change from baseline in blood glucose concentration (mg/dL) in a study arm
</p>
</li>
<li> <p><code>se</code> Numeric data indicating the standard error for the mean change from baseline in blood glucose concentration (mg/dL) in a study arm
</p>
</li>
<li> <p><code>n</code> Numeric data indicating the number in each arm at each follow-up time
</p>
</li>
</ul>
<h3>Details</h3>

<p><code>alog_pcfb</code> is a data frame in long format (one row per observation, arm and study),
with the variables <code>studyID</code>, <code>clinicaltrialGov_ID</code>, <code>agent</code>, <code>dose</code>, <code>treatment</code>, <code>time</code>, <code>y</code>, <code>se</code>, and <code>n</code>.
</p>


<h3>References</h3>

<p>Langford O, Aronson JK, van Valkenhoef G, Stevens RJ (2016).
“Methods for meta-analysis of pharmacodynamic dose-response data with application to multi-arm studies of alogliptin.”
<em>Stat Methods Med Res</em>.
ISSN 1477-0334 (Electronic) 0962-2802 (Linking), <a href="https://doi.org/10.1177/0962280216637093">doi:10.1177/0962280216637093</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/26994216/">https://pubmed.ncbi.nlm.nih.gov/26994216/</a>.
</p>


</div>